VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $26,809,000 | -30.9% | 1,870,814 | -16.5% | 0.20% | -38.3% |
Q2 2017 | $38,774,000 | +20.1% | 2,241,254 | -23.4% | 0.32% | +23.7% |
Q1 2017 | $32,284,000 | +47.2% | 2,926,941 | +93.8% | 0.26% | +44.0% |
Q4 2016 | $21,932,000 | -34.9% | 1,510,494 | +10.0% | 0.18% | -41.7% |
Q3 2016 | $33,704,000 | -41.1% | 1,372,888 | -51.6% | 0.31% | -41.9% |
Q2 2016 | $57,185,000 | -1.2% | 2,839,364 | +29.1% | 0.54% | +0.9% |
Q1 2016 | $57,860,000 | +8787.9% | 2,200,000 | +60141.0% | 0.53% | +6550.0% |
Q3 2015 | $651,000 | -1.5% | 3,652 | -20.9% | 0.01% | -27.3% |
Q4 2014 | $661,000 | -91.9% | 4,619 | -92.9% | 0.01% | -94.0% |
Q2 2014 | $8,204,000 | +1.6% | 65,047 | +6.2% | 0.18% | -18.0% |
Q1 2014 | $8,075,000 | – | 61,250 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |